Literature DB >> 16680572

ADAMs, cell migration and cancer.

Joaquín Arribas1, Joan J Bech-Serra, Belén Santiago-Josefat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16680572     DOI： 10.1007/s10555-006-7889-6

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  44 in total

1.  ADAM17 regulates prostate cancer cell proliferation through mediating cell cycle progression by EGFR/PI3K/AKT pathway.

Authors:  Ping Lin; Xicai Sun; Tian Feng; Haifeng Zou; Ying Jiang; Zijun Liu; Dandan Zhao; Xiaoguang Yu
Journal:  Mol Cell Biochem       Date:  2011-08-12       Impact factor: 3.396

Review 2.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

3.  Identification of binding peptides of the ADAM15 disintegrin domain using phage display.

Authors:  Jing Wu; Min-Chen Wu; Lian-Fen Zhang; Jian-Yong Lei; Lei Feng; Jian Jin
Journal:  J Biosci       Date:  2009-06       Impact factor: 1.826

Review 4.  Functional interplay between tetraspanins and proteases.

Authors:  María Yáñez-Mó; Maria Dolores Gutiérrez-López; Carlos Cabañas
Journal:  Cell Mol Life Sci       Date:  2011-06-18       Impact factor: 9.261

Review 5.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

Review 6.  Regulation of thrombospondin1 by extracellular proteases.

Authors:  M Luisa Iruela-Arispe
Journal:  Curr Drug Targets       Date:  2008-10       Impact factor: 3.465

Review 7.  ADAM proteases: ligand processing and modulation of the Notch pathway.

Authors:  A Zolkiewska
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

8.  ADAM2 interactions with mouse eggs and cell lines expressing α4/α9 (ITGA4/ITGA9) integrins: implications for integrin-based adhesion and fertilization.

Authors:  Ulyana V Desiderio; Xiaoling Zhu; Janice P Evans
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

9.  ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.

Authors:  Shuang-Shuang Ni; Ji Zhang; Wei-Li Zhao; Xiao-Chun Dong; Jin-Lin Wang
Journal:  Tumour Biol       Date:  2013-03-09

10.  Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse.

Authors:  C Kahlert; H Weber; C Mogler; F Bergmann; P Schirmacher; H G Kenngott; U Matterne; N Mollberg; N N Rahbari; U Hinz; M Koch; M Aigner; J Weitz
Journal:  Br J Cancer       Date:  2009-07-14       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.